Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Despite the current available therapies for opioid-dependent patients, most patients relapse.
This research project focuses on the development of a novel compound, cannabidiol, to
modulate opioid craving in humans based on animal models showing its selective effectiveness
to inhibit drug-seeking behavior. The development of a targeted treatment for opioid relapse
would be of tremendous medical and public health value.